Diamidine compounds: selective uptake and targeting in Plasmodium falciparum

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Extensive drug resistance in Plasmodium falciparum necessitates the development of new antimalarial agents.
• Diamidine compounds have demonstrated significant antimalarial potential.

Purpose of the Study:

• To investigate the antimalarial activity of diamidine compounds.
• To elucidate the mechanism of action and cellular uptake of these compounds in Plasmodium falciparum.

Main Methods:

• In vitro assays to assess antimalarial activity and inhibition of hemozoin formation.
• Measurement of pentamidine accumulation in infected and uninfected erythrocytes.
• Investigation of transport kinetics and effects of inhibitors and counter-ions.

Main Results:

• Pentamidine, a lead diamidine compound, is selectively concentrated in Plasmodium falciparum-infected erythrocytes.
• Diamidines bind to ferriprotoporphyrin IX (FPIX) and inhibit hemozoin formation, crucial for parasite survival.
• Pentamidine uptake occurs via an induced permeability pathway, distinct from uninfected cells and sensitive to specific inhibitors.

Conclusions:

• Diamidine compounds exhibit dual selectivity against Plasmodium falciparum, targeting both entry and molecular mechanisms specific to infected cells.
• The use of induced permeability pathways represents a novel strategy for antimalarial drug development.
• These findings offer a promising new avenue for antiparasitic chemotherapy with enhanced selectivity.